According to the news of Japan's news agency, Japan is studying the use of the anti-influenza drug Avigan, which is commonly known as Farpiravir, to treat COVID-19 patients.
Farpiravir is an antiviral drug, which can inhibit RNA polymerase. Farpiravir is used to treat influenza A, including avian influenza and influenza A (H1N1) infection.